Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/27/2012 | WO2012127496A1 Stable pharmaceutical compositions of lornoxicam or salts thereof |
09/27/2012 | WO2012127277A2 Bendamustine anionic-catioinic cyclopolysaccharide compositions |
09/27/2012 | WO2012126941A1 A composition and method |
09/27/2012 | WO2012126833A1 New conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids |
09/27/2012 | WO2012126770A1 Doxylamine resinate complex |
09/27/2012 | WO2012126359A1 A drug carrier for tumor-targeted therapy, its preparation method and its use |
09/27/2012 | WO2012126277A1 External reverse thermo-sensitive reversible aquagel composition for treating hair loss |
09/27/2012 | WO2012126115A1 Star polymer nanoshells and methods of preparation thereof |
09/27/2012 | WO2012105887A8 Active principle for mitigating undesired medical conditions |
09/27/2012 | WO2012103985A3 Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications |
09/27/2012 | WO2012097763A3 A carrier for oromucosal, especially sublingual administration of physiologically active substances |
09/27/2012 | WO2012097255A3 Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus |
09/27/2012 | WO2012071461A3 Method of making and using fluorescent-tagged nanoparticles and microarrays |
09/27/2012 | WO2012071452A3 Stealth polymeric particles for delivery of bioactive or diagnostic agents |
09/27/2012 | WO2012020214A3 Anti-microbial metal organic framework |
09/27/2012 | US20120245289 Polymer-factor viii moiety conjugates |
09/27/2012 | US20120245234 Cosmetic and dermatologic composition and uses thereof |
09/27/2012 | US20120245233 Crosslinked pigment dispersion based on structured vinyl polymeric dispersants |
09/27/2012 | US20120245218 Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery |
09/27/2012 | US20120245156 Oral lyophilized compositions |
09/27/2012 | US20120245134 Androgen pharmaceutical composition and method for treating depression |
09/27/2012 | US20120245107 Methods of reducing the proliferation and viablility of microbial agents |
09/27/2012 | US20120244597 Polymer factor viii moiety conjugates |
09/27/2012 | US20120244197 Film-Like Pharmaceutical Dosage Forms |
09/27/2012 | US20120244194 Pharmaceutical Compositions Comprising Terbinafine |
09/27/2012 | US20120244177 Pharmaceutical composition for treatment of dry eye syndrome |
09/27/2012 | US20120244134 Process for preparing aqueous dispersions containing high concentration of nano/submicron, hydrophobic, functional compounds |
09/27/2012 | US20120244097 Reversely thermo-reversible hydrogel compositions |
09/27/2012 | US20120244093 Emulsifier-free, polymer-stabilized foam formulations |
09/27/2012 | US20120244089 Use of thiazole compound in flavor applications |
09/27/2012 | US20120244088 Organomodified carbosiloxane monomers containing compositions and uses thereof |
09/27/2012 | CA2830901A1 Immunogenic compositions in particulate form and methods for producing the same |
09/27/2012 | CA2830342A1 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor |
09/27/2012 | CA2830012A1 New conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids |
09/27/2012 | CA2829755A1 Treatment of proliferative disorders with a chemiluminescent agent |
09/27/2012 | CA2828477A1 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins |
09/27/2012 | CA2824864A1 Cytotoxic benzodiazepine derivatives |
09/27/2012 | CA2805805A1 Bendamustine anionic-catioinic cyclopolysaccharide compositions |
09/26/2012 | EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile |
09/26/2012 | EP2502938A2 Antibodies and immunoconjugates and uses therefor |
09/26/2012 | EP2502937A2 Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use |
09/26/2012 | EP2502935A2 Improved antibodies having altered effector function and methods for making the same |
09/26/2012 | EP2502928A1 Process for production of purified egg-yolk phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition comprising purified egg-yolk phospholipid composition produced by the process |
09/26/2012 | EP2502882A1 Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same |
09/26/2012 | EP2502617A1 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the methods |
09/26/2012 | EP2501413A2 Acid salt forms of polymer-drug conjugates and alkoxylation methods |
09/26/2012 | EP2501412A1 Salt form of a multi-arm polymer-drug conjugate |
09/26/2012 | EP2501411A1 Methods for improving oral delivery |
09/26/2012 | EP2501408A1 Formulations of antibody |
09/26/2012 | EP2501402A1 Suppression of cancer metastasis |
09/26/2012 | EP2501389A1 Polysaccharide / bmp complexes which are soluble at physiological ph |
09/26/2012 | EP2501388A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions |
09/26/2012 | EP2501372A2 Intravenous infusion of curcumin and a calcium channel blocker |
09/26/2012 | EP2501369A1 Drug-loaded fibers |
09/26/2012 | EP2501367A1 Formulation for hgh and rhigf-1 combination |
09/26/2012 | EP2501361A1 Method for treating retinal conditions using an intraocular tamponade |
09/26/2012 | CN1674866B New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
09/26/2012 | CN102695516A Eradicating agent and eradication method for helicobacter pylori |
09/26/2012 | CN102695514A S-adenosylmethionine formulations with enhanced bioavailability |
09/26/2012 | CN102695501A Fragmented hydrogels |
09/26/2012 | CN102695500A Polysaccharide based hydrogels |
09/26/2012 | CN102695497A Injectable aqueous ophthalmic composition and method of use therefor |
09/26/2012 | CN102690857A Method for preparing medium-low molecular weight dextran by using biological method |
09/26/2012 | CN102690804A Polyethylene-glycol-modified recombinant homosapiensarginase I, preparation method thereof and application thereof |
09/26/2012 | CN102690424A Composite temperature-sensitive aquagel and preparation method thereof |
09/26/2012 | CN102690354A Recombined dimerization antithrombin III-Fc fusion protein and mammalian cell efficient expression system thereof |
09/26/2012 | CN102690352A Fusion protein containing GLP-1, and pharmaceutical compositions and applications thereof |
09/26/2012 | CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof |
09/26/2012 | CN102690318A Tanshinone II A sodium sulfonate crystal compound, preparation method thereof and medicine composition containing tanshinone II A sodium sulfonate crystal compound |
09/26/2012 | CN102688525A Bio-macromolecular hydrogel and preparation method thereof |
09/26/2012 | CN102688501A Proanthocyanidin B2 phospholipid compound, and preparation method and application thereof |
09/26/2012 | CN102688500A Beta-cyclodextrin clathrating technique for borneol in Saimeian emulsifiable paste |
09/26/2012 | CN102688499A Albumin-polyethylene glycol-medicinal molecular conjugate |
09/26/2012 | CN102688498A Taxanes-carboxymethyl chitosan amphiphilic macromolecule prodrug, micelle agent and freeze-dried micelle agent, as well as preparation methods thereof |
09/26/2012 | CN102688497A Preparation method of polypeptide zinc-ferrum supplementary |
09/26/2012 | CN102688496A CTX (Cyclophosphamide)-mediated targeting nanocarrier and nano medicine carrying system |
09/26/2012 | CN102688495A Nano particle carrier having tumor and tumor-associated macrophage targeting multiple functions and preparation thereof |
09/26/2012 | CN102688494A Preparation method of protein drug-carrying magnetic composite nano-material and application thereof |
09/26/2012 | CN102688488A Mucosal adjuvant and its preparation method and use |
09/26/2012 | CN102688482A Injectable sustained-release preparation of polypeptide drug for treating diabetes and production method thereof |
09/26/2012 | CN102688480A Sustained-release preparation of polypeptide drug for treating diabetes and production method thereof |
09/26/2012 | CN102688438A Chinese medicinal orally disintegrating tablets for treating infantile diarrhea |
09/26/2012 | CN102688361A Traditional Chinese medicinal composition for treating dysmenorrhoea and preparation thereof |
09/26/2012 | CN102688358A Suppository for treating prostatitis and preparation method thereof |
09/26/2012 | CN102688345A Composite film for treating oral ulcer, and preparation method thereof |
09/26/2012 | CN102688307A Chinese medicine composition Xueshan Weibao chewable tablet and preparation method thereof |
09/26/2012 | CN102688277A Pharmaceutical composition and preparation for eliminating dampness and dredging obstruction as well as preparation and application for same |
09/26/2012 | CN102688274A Solid dispersion of frankincense extract and preparation method thereof |
09/26/2012 | CN102688273A Soft capsule containing frankincense oil |
09/26/2012 | CN102688252A Acarbose oral solid preparation composition and preparation method thereof |
09/26/2012 | CN102688251A Simethicone composition |
09/26/2012 | CN102688243A Clathrate compound of perphenazine cyclodextrin derivative, and preparation method thereof |
09/26/2012 | CN102688241A Tamper resistant oral pharmaceutical dosage forms comprising opioid analgesic |
09/26/2012 | CN102688237A Stable Azelnidipine composition |
09/26/2012 | CN102688236A Candesartan cilexetil and amlodipine tablet composition and preparation method thereof |
09/26/2012 | CN102688224A Device and pharmaceutical composition enhancing administration efficiency |
09/26/2012 | CN102688223A Anti-cancer drug-loading nanofiber film and preparation method thereof |
09/26/2012 | CN102688221A Method for preparing aceclofenac enteric microcapsules |
09/26/2012 | CN102688220A Tilmicosin micro-capsule preparation and preparation method thereof |
09/26/2012 | CN102688219A Sulforaphane microencapsulation method |